On Monday, Arcus Biosciences Inc (NYSE: RCUS) was 3.43% up from the session before settling in for the closing price of $9.33. A 52-week range for RCUS has been $6.50 – $18.98.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -10.20% over the last five years. When this article was written, the company’s average yearly earnings per share was at -46.97%. With a float of $64.62 million, this company’s outstanding shares have now reached $105.90 million.
The firm has a total of 627 workers. Let’s measure their productivity. In terms of profitability, gross margin is 96.45%, operating margin of -309.22%, and the pretax margin is -277.3%.
Arcus Biosciences Inc (RCUS) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Arcus Biosciences Inc stocks. The insider ownership of Arcus Biosciences Inc is 38.97%, while institutional ownership is 62.50%. The most recent insider transaction that took place on Feb 27 ’25, was worth 201,200. In this transaction Director of this company bought 20,000 shares at a rate of $10.06, taking the stock ownership to the 28,400 shares. Before that another transaction happened on Feb 27 ’25, when Company’s Chief Executive Officer bought 19,800 for $10.18, making the entire transaction worth $201,465. This insider now owns 2,554,160 shares in total.
Arcus Biosciences Inc (RCUS) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -46.97% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -6.14% during the next five years compared to -10.20% drop over the previous five years of trading.
Arcus Biosciences Inc (NYSE: RCUS) Trading Performance Indicators
You can see what Arcus Biosciences Inc (RCUS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.37. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.25.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.19, a number that is poised to hit -1.13 in the next quarter and is forecasted to reach -4.49 in one year’s time.
Technical Analysis of Arcus Biosciences Inc (RCUS)
Analysing the last 5-days average volume posted by the [Arcus Biosciences Inc, RCUS], we can find that recorded value of 0.82 million was lower than the volume posted last year of 1.08 million. As of the previous 9 days, the stock’s Stochastic %D was 77.38%.
During the past 100 days, Arcus Biosciences Inc’s (RCUS) raw stochastic average was set at 60.69%, which indicates a significant decrease from 84.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.49 in the past 14 days, which was lower than the 0.56 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.90, while its 200-day Moving Average is $12.14. Now, the first resistance to watch is $9.83. This is followed by the second major resistance level at $10.01. The third major resistance level sits at $10.34. If the price goes on to break the first support level at $9.32, it is likely to go to the next support level at $8.99. Now, if the price goes above the second support level, the third support stands at $8.81.
Arcus Biosciences Inc (NYSE: RCUS) Key Stats
There are 105,885K outstanding shares of the company, which has a market capitalization of 1.02 billion. As of now, sales total 258,000 K while income totals -283,000 K. Its latest quarter income was 28,000 K while its last quarter net income were -112,000 K.
